Aviana Molecular Technologies
Aviana Molecular Technologies is an Orlando-based point of care diagnostic company developing miniaturized biosensors capable of attaching to smartphones or smart devices through wireless connections. Their innovative platform aims to provide rapid, sensitive, and accurate detection of infectious diseases, biomarkers, and proteins in various settings, supporting immediate treatment and health data capture. The company leverages advanced RF sensor technology, microfluidics, and cellular communication developments to create portable, cost-effective diagnostic tools suitable for both sophisticated health systems and resource-limited environments. Their mission is to revolutionize healthcare diagnostics and improve global health outcomes.
Industries
Nr. of Employees
small (1-50)
Aviana Molecular Technologies
Patents
Biocoated piezoelectric biosensor platform for point-of-care diagnostic use
US-10161934-B2
View Details
Biocoated piezoelectric biosensor platform for point-of-care diagnostic use
US-10161934-B2
View DetailsProducts
Real-time sensing cartridge
Single-use, credit-card-sized biosensor cartridge containing the functionalized sensor surface for rapid, quantitative detection of biomarkers and infectious agents from small biological samples.
Compact fieldable reader
Reusable portable reader that interfaces with disposable cartridges to perform real-time interrogation, provide calibrated quantitative readouts, and transmit results to EMRs or public health systems.
Diagnostic assays for infectious diseases (examples: Lyme disease, SARS‑CoV‑2)
Assay implementations on the cartridge/reader platform intended to detect acute and prior infections and, in the case of SARS‑CoV‑2, to distinguish infection versus prior infection or vaccination.
Real-time sensing cartridge
Single-use, credit-card-sized biosensor cartridge containing the functionalized sensor surface for rapid, quantitative detection of biomarkers and infectious agents from small biological samples.
Compact fieldable reader
Reusable portable reader that interfaces with disposable cartridges to perform real-time interrogation, provide calibrated quantitative readouts, and transmit results to EMRs or public health systems.
Diagnostic assays for infectious diseases (examples: Lyme disease, SARS‑CoV‑2)
Assay implementations on the cartridge/reader platform intended to detect acute and prior infections and, in the case of SARS‑CoV‑2, to distinguish infection versus prior infection or vaccination.
Expertise Areas
- Point-of-care diagnostics
- Biosensor transduction and SAW-based sensing
- Microfluidics integration
- Surface chemistry and capture-agent functionalization
Key Technologies
- Surface acoustic wave (SAW) sensors
- Piezoelectric radio-frequency biosensing
- Microfluidics
- Semiconductor electronics
News & Updates
Recognition among 21 Fibonacci Finalists in the Cade Prize competition, celebrating innovation and creative problem-solving in their field.
The Florida Institute announced that Aviana received follow-on second round financing after achieving significant development milestones, supporting their development of miniaturized biosensors for health monitoring.
Announcement of John M. Starcher, Jr. Esq. joining the board, with his extensive healthcare leadership background, including CEO of Mercy Health.
Recognition for innovative contributions in healthcare diagnostics.
Recognition among 21 Fibonacci Finalists in the Cade Prize competition, celebrating innovation and creative problem-solving in their field.
The Florida Institute announced that Aviana received follow-on second round financing after achieving significant development milestones, supporting their development of miniaturized biosensors for health monitoring.
Announcement of John M. Starcher, Jr. Esq. joining the board, with his extensive healthcare leadership background, including CEO of Mercy Health.
Recognition for innovative contributions in healthcare diagnostics.